Technical Specifications

Specification	Details
Product Name	CJC-1295
Chemical Classification	Synthetic Peptide
Molecular Formula	C₁₅₂H₂₅₂N₄₄O₄₂
Molecular Weight	~3367.0 g/mol
Sequence Length	30 amino acids
Sequence	Modified GHRH Analog
Purity	≥98%
Form	Lyophilized Peptide
Classification	Growth Hormone-Releasing Hormone Analog
Intended Use	Laboratory Research Only

---

Product Overview

CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) developed to provide a research model for investigating GHRH receptor signaling and growth hormone-related pathways.

CJC-1295 has been studied for its interaction with the growth hormone-releasing hormone receptor (GHRHR) and its ability to provide prolonged signaling compared with shorter GHRH peptide fragments.

The compound is particularly relevant to research involving growth hormone regulation, pituitary signaling, peptide-receptor interactions, endocrine pathways, and synthetic peptide pharmacology.

---

Mechanism of Action

Research has investigated CJC-1295 in relation to several biological mechanisms:

GHRH Receptor Signaling

CJC-1295 acts as a GHRH analog and provides a model for studying activation of the growth hormone-releasing hormone receptor (GHRHR).

Growth Hormone Pathways

Experimental research has examined CJC-1295 in relation to signaling pathways associated with growth hormone regulation.

Pituitary Signaling

Research models have investigated GHRH analogs in relation to pituitary somatotroph cells and endocrine signal transduction.

Peptide Stability

CJC-1295 has structural characteristics that make it useful for research involving peptide stability and prolonged receptor-mediated signaling.

Structure-Activity Relationships

Its modified peptide structure provides opportunities to investigate how sequence and chemical modifications influence receptor interactions and biological activity.

---

Research Applications

CJC-1295 may be investigated in laboratory settings involving:

• GHRH receptor research
• Growth hormone signaling
• Pituitary-cell research
• Endocrine signaling studies
• Peptide-receptor interaction research
• Synthetic peptide pharmacology
• Peptide stability studies
• Structure-activity relationship research
• Neuroendocrine research
• Hormonal signaling pathways

---

Handling & Storage

• Store the lyophilized peptide according to the manufacturer’s recommended conditions.
• Protect from excessive heat, moisture, and direct sunlight.
• Keep the product sealed in its original packaging until required for laboratory research.
• Store at approximately −20°C when consistent with supplier specifications.
• Follow the applicable batch Certificate of Analysis for exact storage requirements.
• Minimize unnecessary temperature fluctuations.
• Avoid repeated freeze-thaw cycles where applicable.
• Protect the material from prolonged exposure to moisture and light.

---

Product Features

✓ Research Grade Quality

✓ ≥98% Purity

✓ Synthetic GHRH Analog

✓ Growth Hormone-Releasing Hormone Research Compound

✓ 30-Amino-Acid Peptide

✓ Lyophilized for Stability

✓ Carefully Packaged

✓ Laboratory Research Use Only

---

Important Notice

This product is intended exclusively for laboratory research purposes.

It is not intended for human or veterinary use, administration, injection, consumption, diagnosis, treatment, cure, or prevention of any disease.

CJC-1295 is an investigational research peptide. Laboratory and preclinical findings should not be interpreted as established evidence of safety or efficacy for human use.

CJC-1295 and CJC-1295 with DAC are distinct formulations. The exact molecular structure, presence or absence of DAC modification, purity, salt form, and analytical specifications should be verified against the applicable batch Certificate of Analysis (CoA).

By purchasing this product, the purchaser acknowledges that it will be handled only by qualified professionals in appropriate laboratory environments and used in accordance with applicable laws, regulations, and institutional protocols.

---

Frequently Asked Questions

What is CJC-1295?

CJC-1295 is a synthetic GHRH analog investigated for its interaction with growth hormone-releasing hormone receptors and related endocrine signaling pathways.

What is CJC-1295 researched for?

CJC-1295 is investigated in research involving GHRH receptor signaling, growth hormone pathways, pituitary-cell biology, endocrine signaling, peptide-receptor interactions, and peptide stability.

Is CJC-1295 a peptide?

Yes. CJC-1295 is a synthetic peptide analog of GHRH.

What form does CJC-1295 come in?

Research-grade CJC-1295 is commonly supplied as a lyophilized (freeze-dried) peptide.

What is the purity of CJC-1295?

This product is specified at a minimum purity of ≥98%, subject to the applicable batch Certificate of Analysis.

Is CJC-1295 the same as CJC-1295 with DAC?

No. CJC-1295 and CJC-1295 with DAC refer to different molecular forms. The specific formulation should be confirmed using the supplier’s product specification and CoA.

Is CJC-1295 intended for human use?

No. This research-grade product is supplied strictly for laboratory research purposes and is not intended for human or veterinary use.

How should CJC-1295 be stored?

The lyophilized peptide should be protected from heat, moisture, and direct sunlight and stored according to the manufacturer’s recommended conditions. Always refer to the batch-specific Certificate of Analysis for exact storage requirements.